DK0978284T3 - Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister - Google Patents

Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister

Info

Publication number
DK0978284T3
DK0978284T3 DK98953058T DK98953058T DK0978284T3 DK 0978284 T3 DK0978284 T3 DK 0978284T3 DK 98953058 T DK98953058 T DK 98953058T DK 98953058 T DK98953058 T DK 98953058T DK 0978284 T3 DK0978284 T3 DK 0978284T3
Authority
DK
Denmark
Prior art keywords
keto
prostaglandin
compounds
endothelin antagonists
endothelin
Prior art date
Application number
DK98953058T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK0978284T3 publication Critical patent/DK0978284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
DK98953058T 1997-11-28 1998-11-16 Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister DK0978284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32783297 1997-11-28
PCT/JP1998/005143 WO1999027934A1 (fr) 1997-11-28 1998-11-16 Antagoniste d'endotheline

Publications (1)

Publication Number Publication Date
DK0978284T3 true DK0978284T3 (da) 2008-10-27

Family

ID=18203488

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953058T DK0978284T3 (da) 1997-11-28 1998-11-16 Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister

Country Status (17)

Country Link
US (1) US6197821B1 (zh)
EP (1) EP0978284B1 (zh)
JP (1) JP4319256B2 (zh)
KR (1) KR100648868B1 (zh)
CN (1) CN1206997C (zh)
AT (1) ATE401894T1 (zh)
AU (1) AU739343B2 (zh)
CA (1) CA2279267C (zh)
DE (1) DE69839767D1 (zh)
DK (1) DK0978284T3 (zh)
ES (1) ES2310013T3 (zh)
HK (1) HK1025521A1 (zh)
NO (1) NO328460B1 (zh)
NZ (1) NZ336960A (zh)
PT (1) PT978284E (zh)
TW (1) TW592701B (zh)
WO (1) WO1999027934A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
CN1753680B (zh) * 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
ES2375082T3 (es) * 2005-01-27 2012-02-24 Sucampo Ag Composición para el tratamiento de trastornos del sistema nervioso central.
JP5213448B2 (ja) * 2005-03-04 2013-06-19 スキャンポ・アーゲー 末梢血管疾患の処置のための方法および組成物
CN102391237B (zh) * 2006-02-07 2014-07-16 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
JP5377970B2 (ja) * 2006-02-28 2013-12-25 スキャンポ・アーゲー 慢性閉塞性肺疾患を処置するための方法および組成物
US20100022568A1 (en) * 2006-04-13 2010-01-28 Actelion Pharmaceeuticals Ltd. Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
US20080207759A1 (en) * 2007-02-27 2008-08-28 Sucampo Ag Method for protecting mitochondria
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
EP2516412A4 (en) * 2009-12-18 2013-05-29 Apotex Pharmachem Inc PROCESS FOR CLEANING LUBIPROSTON
CN104557845B (zh) * 2015-01-13 2020-12-22 齐鲁制药有限公司 一种鲁比前列酮化合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853951A (en) 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
US4018811A (en) 1972-02-11 1977-04-19 American Cyanamid Company 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof
US3981868A (en) 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
US5362751A (en) 1988-05-11 1994-11-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Tracheobronchodilator using 16-substituted PGEs
EP0343904B1 (en) 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
JPH0232031A (ja) * 1988-07-22 1990-02-01 Nippon Steel Chem Co Ltd イソプロピル化ｐ‐ターフェニル類の製造法
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
TW249226B (zh) 1990-04-04 1995-06-11 Aderk Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
JPH107574A (ja) 1996-06-17 1998-01-13 R Tec Ueno:Kk エンドセリン拮抗剤

Also Published As

Publication number Publication date
HK1025521A1 (en) 2000-11-17
ES2310013T3 (es) 2008-12-16
ATE401894T1 (de) 2008-08-15
NO993647L (no) 1999-09-27
AU1053799A (en) 1999-06-16
KR20000070508A (ko) 2000-11-25
AU739343B2 (en) 2001-10-11
CN1206997C (zh) 2005-06-22
EP0978284A1 (en) 2000-02-09
JP4319256B2 (ja) 2009-08-26
CA2279267C (en) 2010-01-12
KR100648868B1 (ko) 2006-11-24
CA2279267A1 (en) 1999-06-10
PT978284E (pt) 2008-10-07
NO328460B1 (no) 2010-02-22
NZ336960A (en) 2001-02-23
EP0978284B1 (en) 2008-07-23
TW592701B (en) 2004-06-21
US6197821B1 (en) 2001-03-06
DE69839767D1 (de) 2008-09-04
NO993647D0 (no) 1999-07-27
EP0978284A4 (en) 2001-07-18
CN1251040A (zh) 2000-04-19
WO1999027934A1 (fr) 1999-06-10

Similar Documents

Publication Publication Date Title
DK0978284T3 (da) Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
EA200000381A1 (ru) Препарат 2-метил-тиено-бензодиазепина
DE69714698T2 (de) Endothelin-antagonisten
PT911333E (pt) Derivados de pirazolo¬4,3-d|pirimidina e composicoes farmaceuticas que os contenham
CO4940465A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
BR9902086A (pt) Formulações farmacêuticas.
FR2768916B1 (fr) Agrafe d'osteotomie tibiale
BR9709395A (pt) Calçado aperfeiçoado
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
ES2179881T3 (es) Antagonistas de endotelina.
TR199501132A2 (tr) Nörokinin karsitlari (antagonistleri).
FR2799148B3 (fr) Agrafeuse avec indication de la quantite d'agrafes restantes
BR9804027A (pt) Novos beta-ceto ésteres
ATE267602T1 (de) 2-methyl-thieno-benzodiazepin-formulierung
BR9813817A (pt) Análogos de hemiasterlina
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
EA200401137A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
HN1999000027A (es) Nuevas composiciones herbicidas
EA200500878A1 (ru) Кальцилитические соединения
NO20000518L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat
ITMI20021380A1 (it) Corpo illuminante per l'emissione di un fascio luminoso a lama